Industry Research Reports

Home > Reports > Medical Care > Global New Chemical Entities (NCE) CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global New Chemical Entities (NCE) CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published: 2025-01-06

Pages: 95 Pages

Report ld: 3524360

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global New Chemical Entities (NCE) CDMO market size was US$ 2614 million in 2024 and is forecast to a readjusted size of US$ 5607 million by 2031 with a CAGR of 11.4% during the forecast period 2025-2031. 
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.

The North America New Chemical Entities (NCE) CDMO market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key players of New Chemical Entities (NCE) CDMO include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global New Chemical Entities (NCE) CDMO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global New Chemical Entities (NCE) CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

Market Segmentation

Report Metric
Details
Report Title
Global New Chemical Entities (NCE) CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global New Chemical Entities (NCE) CDMO Companies Covered
KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, Aarti Pharmalabs Limited (APL), Cerbios-Pharma SA, PharmaBlock Sciences Nanjing Inc
Global New Chemical Entities (NCE) CDMO Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global New Chemical Entities (NCE) CDMO Market, Segment by Type
Peptide NCE

Oligonucleotide NCE

Other
Global New Chemical Entities (NCE) CDMO Market, Segment by Application
Tumors

Cardiovascular Diseases

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of New Chemical Entities (NCE) CDMO in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of New Chemical Entities (NCE) CDMO manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Chemical Entities (NCE) CDMO revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market by Type
        1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
        1.2.2 Peptide NCE
        1.2.3 Oligonucleotide NCE
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
        1.3.2 Tumors
        1.3.3 Cardiovascular Diseases
        1.3.4 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global New Chemical Entities (NCE) CDMO Market Perspective (2020-2031)
    2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
    2.3 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Region (2020-2025)
    2.4 Global New Chemical Entities (NCE) CDMO Revenue Forecast by Region (2026-2031)
    2.5 Major Region and Emerging Market Analysis
        2.5.1 North America New Chemical Entities (NCE) CDMO Market Size and Prospective (2020-2031)
        2.5.2 Europe New Chemical Entities (NCE) CDMO Market Size and Prospective (2020-2031)
        2.5.3 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size and Prospective (2020-2031)
        2.5.4 Latin America New Chemical Entities (NCE) CDMO Market Size and Prospective (2020-2031)
        2.5.5 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size and Prospective (2020-2031)

 3 Breakdown Data by Type
    3.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Type (2020-2025)
    3.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031)
    3.3 Different Types New Chemical Entities (NCE) CDMO Representative Players

 4 Breakdown Data by Application
    4.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Application (2020-2025)
    4.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031)
    4.3 New Sources of Growth in New Chemical Entities (NCE) CDMO Application

 5 Competition Landscape by Players
    5.1 Global Top Players by Revenue
        5.1.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue (2020-2025)
        5.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Players (2020-2025)
    5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    5.3 Players Covered: Ranking by New Chemical Entities (NCE) CDMO Revenue
    5.4 Global New Chemical Entities (NCE) CDMO Market Concentration Analysis
        5.4.1 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio (CR5 and HHI)
        5.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) CDMO Revenue in 2024
    5.5 Global Key Players of New Chemical Entities (NCE) CDMO Head office and Area Served
    5.6 Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application
    5.7 Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry
    5.8 Mergers & Acquisitions, Expansion Plans

 6 Region Analysis
    6.1 North America Market: Players, Segments and Downstream
        6.1.1 North America New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025)
        6.1.2 North America Market Size by Type
            6.1.2.1 North America New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025)
            6.1.2.2 North America New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
        6.1.3 North America Market Size by Application
            6.1.3.1 North America New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025)
            6.1.3.2 North America New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
        6.1.4 North America Market Trend and Opportunities
    6.2 Europe Market: Players, Segments and Downstream
        6.2.1 Europe New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025)
        6.2.2 Europe Market Size by Type
            6.2.2.1 Europe New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025)
            6.2.2.2 Europe New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
        6.2.3 Europe Market Size by Application
            6.2.3.1 Europe New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025)
            6.2.3.2 Europe New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
        6.2.4 Europe Market Trend and Opportunities
    6.3 Asia-Pacific Market: Players, Segments and Downstream
        6.3.1 Asia-Pacific New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025)
        6.3.2 Asia-Pacific Market Size by Type
            6.3.2.1 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025)
            6.3.2.2 Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
        6.3.3 Asia-Pacific Market Size by Application
            6.3.3.1 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025)
            6.3.3.2 Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
        6.3.4 Asia-Pacific Market Trend and Opportunities
    6.4 Latin America Market: Players, Segments and Downstream
        6.4.1 Latin America New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025)
        6.4.2 Latin America Market Size by Type
            6.4.2.1 Latin America New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025)
            6.4.2.2 Latin America New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
        6.4.3 Latin America Market Size by Application
            6.4.3.1 Latin America New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025)
            6.4.3.2 Latin America New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
        6.4.4 Latin America Market Trend and Opportunities
    6.5 Middle East & Africa Market: Players, Segments and Downstream
        6.5.1 Middle East & Africa New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025)
        6.5.2 Middle East & Africa Market Size by Type
            6.5.2.1 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025)
            6.5.2.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
        6.5.3 Middle East & Africa Market Size by Application
            6.5.3.1 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025)
            6.5.3.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
        6.5.4 Middle East & Africa Market Trend and Opportunities

 7 Key Players Profiles
    7.1 KATSURA CHEMICAL CO., LTD
        7.1.1 KATSURA CHEMICAL CO., LTD Company Details
        7.1.2 KATSURA CHEMICAL CO., LTD Business Overview
        7.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Introduction
        7.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.1.5 KATSURA CHEMICAL CO., LTD Recent Development
    7.2 Regis Custom API
        7.2.1 Regis Custom API Company Details
        7.2.2 Regis Custom API Business Overview
        7.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Introduction
        7.2.4 Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.2.5 Regis Custom API Recent Development
    7.3 Neuland Laboratories Ltd.
        7.3.1 Neuland Laboratories Ltd. Company Details
        7.3.2 Neuland Laboratories Ltd. Business Overview
        7.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Introduction
        7.3.4 Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.3.5 Neuland Laboratories Ltd. Recent Development
    7.4 Aspen API
        7.4.1 Aspen API Company Details
        7.4.2 Aspen API Business Overview
        7.4.3 Aspen API New Chemical Entities (NCE) CDMO Introduction
        7.4.4 Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.4.5 Aspen API Recent Development
    7.5 Sai Life Sciences
        7.5.1 Sai Life Sciences Company Details
        7.5.2 Sai Life Sciences Business Overview
        7.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Introduction
        7.5.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.5.5 Sai Life Sciences Recent Development
    7.6 Fermion
        7.6.1 Fermion Company Details
        7.6.2 Fermion Business Overview
        7.6.3 Fermion New Chemical Entities (NCE) CDMO Introduction
        7.6.4 Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.6.5 Fermion Recent Development
    7.7 Dipharma Francis Srl (Dipharma)
        7.7.1 Dipharma Francis Srl (Dipharma) Company Details
        7.7.2 Dipharma Francis Srl (Dipharma) Business Overview
        7.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Introduction
        7.7.4 Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.7.5 Dipharma Francis Srl (Dipharma) Recent Development
    7.8 Cohance
        7.8.1 Cohance Company Details
        7.8.2 Cohance Business Overview
        7.8.3 Cohance New Chemical Entities (NCE) CDMO Introduction
        7.8.4 Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.8.5 Cohance Recent Development
    7.9 Suven Pharma
        7.9.1 Suven Pharma Company Details
        7.9.2 Suven Pharma Business Overview
        7.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Introduction
        7.9.4 Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.9.5 Suven Pharma Recent Development
    7.10 Syngene
        7.10.1 Syngene Company Details
        7.10.2 Syngene Business Overview
        7.10.3 Syngene New Chemical Entities (NCE) CDMO Introduction
        7.10.4 Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.10.5 Syngene Recent Development
    7.11 Aarti Pharmalabs Limited (APL)
        7.11.1 Aarti Pharmalabs Limited (APL) Company Details
        7.11.2 Aarti Pharmalabs Limited (APL) Business Overview
        7.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Introduction
        7.11.4 Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.11.5 Aarti Pharmalabs Limited (APL) Recent Development
    7.12 Cerbios-Pharma SA
        7.12.1 Cerbios-Pharma SA Company Details
        7.12.2 Cerbios-Pharma SA Business Overview
        7.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Introduction
        7.12.4 Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.12.5 Cerbios-Pharma SA Recent Development
    7.13 PharmaBlock Sciences Nanjing Inc
        7.13.1 PharmaBlock Sciences Nanjing Inc Company Details
        7.13.2 PharmaBlock Sciences Nanjing Inc Business Overview
        7.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Introduction
        7.13.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
        7.13.5 PharmaBlock Sciences Nanjing Inc Recent Development

 8 New Chemical Entities (NCE) CDMO Market Dynamics
    8.1 New Chemical Entities (NCE) CDMO Industry Trends
    8.2 New Chemical Entities (NCE) CDMO Market Drivers
    8.3 New Chemical Entities (NCE) CDMO Market Challenges
    8.4 New Chemical Entities (NCE) CDMO Market Restraints

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global New Chemical Entities (NCE) CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Market New Chemical Entities (NCE) CDMO Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global New Chemical Entities (NCE) CDMO Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 5. Global New Chemical Entities (NCE) CDMO Revenue Share by Region (2020-2025)
 Table 6. Global New Chemical Entities (NCE) CDMO Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 7. Global New Chemical Entities (NCE) CDMO Revenue Share Forecast by Region (2026-2031)
 Table 8. Global New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 9. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2020-2025)
 Table 10. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 11. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2026-2031)
 Table 12. Representative Players of Each Type
 Table 13. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 14. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2020-2025)
 Table 15. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 16. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2026-2031)
 Table 17. New Sources of Growth in New Chemical Entities (NCE) CDMO Application
 Table 18. Global New Chemical Entities (NCE) CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global New Chemical Entities (NCE) CDMO Market Share by Players (2020-2025)
 Table 20. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)
 Table 21. Ranking of Global Top New Chemical Entities (NCE) CDMO Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by New Chemical Entities (NCE) CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of New Chemical Entities (NCE) CDMO, Headquarters and Area Served
 Table 24. Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application
 Table 25. Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025) & (US$ Million)
 Table 28. North America New Chemical Entities (NCE) CDMO Revenue Market Share by Company (2020-2025)
 Table 29. North America New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 30. North America New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Europe New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025) & (US$ Million)
 Table 32. Europe New Chemical Entities (NCE) CDMO Revenue Market Share by Company (2020-2025)
 Table 33. Europe New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 34. Europe New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 35. Asia-Pacific New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025) & (US$ Million)
 Table 36. Asia-Pacific New Chemical Entities (NCE) CDMO Revenue Market Share by Company (2020-2025)
 Table 37. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 38. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 39. Latin America New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025) & (US$ Million)
 Table 40. Latin America New Chemical Entities (NCE) CDMO Revenue Market Share by Company (2020-2025)
 Table 41. Latin America New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 42. Latin America New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 43. Middle East & Africa New Chemical Entities (NCE) CDMO Revenue by Company (2020-2025) & (US$ Million)
 Table 44. Middle East & Africa New Chemical Entities (NCE) CDMO Revenue Market Share by Company (2020-2025)
 Table 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 47. KATSURA CHEMICAL CO., LTD Company Details
 Table 48. KATSURA CHEMICAL CO., LTD Business Overview
 Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product
 Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 51. KATSURA CHEMICAL CO., LTD Recent Development
 Table 52. Regis Custom API Company Details
 Table 53. Regis Custom API Business Overview
 Table 54. Regis Custom API New Chemical Entities (NCE) CDMO Product
 Table 55. Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 56. Regis Custom API Recent Development
 Table 57. Neuland Laboratories Ltd. Company Details
 Table 58. Neuland Laboratories Ltd. Business Overview
 Table 59. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product
 Table 60. Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 61. Neuland Laboratories Ltd. Recent Development
 Table 62. Aspen API Company Details
 Table 63. Aspen API Business Overview
 Table 64. Aspen API New Chemical Entities (NCE) CDMO Product
 Table 65. Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 66. Aspen API Recent Development
 Table 67. Sai Life Sciences Company Details
 Table 68. Sai Life Sciences Business Overview
 Table 69. Sai Life Sciences New Chemical Entities (NCE) CDMO Product
 Table 70. Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 71. Sai Life Sciences Recent Development
 Table 72. Fermion Company Details
 Table 73. Fermion Business Overview
 Table 74. Fermion New Chemical Entities (NCE) CDMO Product
 Table 75. Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 76. Fermion Recent Development
 Table 77. Dipharma Francis Srl (Dipharma) Company Details
 Table 78. Dipharma Francis Srl (Dipharma) Business Overview
 Table 79. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product
 Table 80. Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 81. Dipharma Francis Srl (Dipharma) Recent Development
 Table 82. Cohance Company Details
 Table 83. Cohance Business Overview
 Table 84. Cohance New Chemical Entities (NCE) CDMO Product
 Table 85. Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 86. Cohance Recent Development
 Table 87. Suven Pharma Company Details
 Table 88. Suven Pharma Business Overview
 Table 89. Suven Pharma New Chemical Entities (NCE) CDMO Product
 Table 90. Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 91. Suven Pharma Recent Development
 Table 92. Syngene Company Details
 Table 93. Syngene Business Overview
 Table 94. Syngene New Chemical Entities (NCE) CDMO Product
 Table 95. Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 96. Syngene Recent Development
 Table 97. Aarti Pharmalabs Limited (APL) Company Details
 Table 98. Aarti Pharmalabs Limited (APL) Business Overview
 Table 99. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product
 Table 100. Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 101. Aarti Pharmalabs Limited (APL) Recent Development
 Table 102. Cerbios-Pharma SA Company Details
 Table 103. Cerbios-Pharma SA Business Overview
 Table 104. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product
 Table 105. Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 106. Cerbios-Pharma SA Recent Development
 Table 107. PharmaBlock Sciences Nanjing Inc Company Details
 Table 108. PharmaBlock Sciences Nanjing Inc Business Overview
 Table 109. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product
 Table 110. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
 Table 111. PharmaBlock Sciences Nanjing Inc Recent Development
 Table 112. New Chemical Entities (NCE) CDMO Market Trends
 Table 113. New Chemical Entities (NCE) CDMO Market Drivers
 Table 114. New Chemical Entities (NCE) CDMO Market Challenges
 Table 115. New Chemical Entities (NCE) CDMO Market Restraints
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. New Chemical Entities (NCE) CDMO Product Picture
 Figure 2. Global New Chemical Entities (NCE) CDMO Market Share by Type: 2024 VS 2031
 Figure 3. Peptide NCE Features
 Figure 4. Oligonucleotide NCE Features
 Figure 5. Other Features
 Figure 6. Global New Chemical Entities (NCE) CDMO Market Share by Application: 2024 VS 2031
 Figure 7. Tumors
 Figure 8. Cardiovascular Diseases
 Figure 9. Other
 Figure 10. New Chemical Entities (NCE) CDMO Report Years Considered
 Figure 11. Global New Chemical Entities (NCE) CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global New Chemical Entities (NCE) CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Region: 2020 VS 2024
 Figure 14. North America New Chemical Entities (NCE) CDMO Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 15. Europe New Chemical Entities (NCE) CDMO Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 16. Asia-Pacific New Chemical Entities (NCE) CDMO Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 17. Latin America New Chemical Entities (NCE) CDMO Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 18. Middle East & Africa New Chemical Entities (NCE) CDMO Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 19. Global New Chemical Entities (NCE) CDMO Market Share by Players in 2024
 Figure 20. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) CDMO Revenue in 2024
 Figure 22. North America New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
 Figure 23. North America New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
 Figure 24. Europe New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
 Figure 25. Europe New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
 Figure 26. Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
 Figure 27. Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
 Figure 28. Latin America New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
 Figure 29. Latin America New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
 Figure 30. Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Type (2020-2025)
 Figure 31. Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Application (2020-2025)
 Figure 32. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 33. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 34. Neuland Laboratories Ltd. Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 35. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 36. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 37. Fermion Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 38. Dipharma Francis Srl (Dipharma) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 39. Cohance Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 40. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 41. Syngene Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 42. Aarti Pharmalabs Limited (APL) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 43. Cerbios-Pharma SA Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 44. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
 Figure 45. Bottom-up and Top-down Approaches for This Report
 Figure 46. Data Triangulation
 Figure 47. Key Executives Interviewed

Description

The global New Chemical Entities (NCE) CDMO market size was US$ 2614 million in 2024 and is forecast to a readjusted size of US$ 5607 million by 2031 with a CAGR of 11.4% during the forecast period 2025-2031. 
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.

The North America New Chemical Entities (NCE) CDMO market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key players of New Chemical Entities (NCE) CDMO include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global New Chemical Entities (NCE) CDMO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global New Chemical Entities (NCE) CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

Market Segmentation